If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDRY.L Regulatory News (SDRY)

  • There is currently no data for SDRY

Superdry plc: PDMR Shareholding

29 Jul 2022 12:30

Superdry plc (SDRY) Superdry plc: PDMR Shareholding 29-Jul-2022 / 12:30 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


SuperdryPlc

 

(Superdry or the Company)

 

29 July 2022

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities (‘PDMR’) and persons closely associated with them (‘PCA’)

 

Settlement of share award and related sale

 

On 28 July 2022, Matt Horwood, Chief Technology Officer, acquired 35,556 ordinary shares of 5 pence each (‘Ordinary Shares’) in the capital of the Company for nil cost in relation to the maturity of a one-off share-based award granted to him on 27 July 2022. The award was granted to Mr Horwood in compensation for amounts forfeited from his previous employer upon joining Superdry.

 

On the same date, 17,217 of such Ordinary Shares acquired by Mr Horwood were sold to fund the resulting tax and employee social security liabilities due in respect of such settlement, at a sale price of £1.3520 per Ordinary Share. Mr Horwood has retained the balance of the Ordinary Shares resulting from maturity of the share award.

 

This announcement, including the notification below, is made in accordance with the requirements of the EU Market Abuse Regulation (as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018).

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Matt Horwood

 

2.

Reason for the notification

a)

Position/status

Chief Technology Officer

b)

Initial notification/Amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Superdry Plc

 

b)

LEI

 213800GAQMT2WL7BW361

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 5 pence each

 

 

ISIN: GB00B60BD277

 

b)

Nature of the transaction

1. Acquisition of Ordinary Shares at nil cost in relation to the settlement of a vested conditional share award; and

 

2.Sale of sufficient Ordinary Shares to cover taxation and employee social security liabilities.

 

c)

Price(s) and volume(s)

Price

1.Nil

2.£1.3520

 

Volume

1.35,556

2.17,217

 

d)

Aggregated information

 

Price

1.Nil

2.£1.3520

 

Volume

1.35,556

2.17,217

 

e)

Date of the transaction

28 July 2022

 

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

 

 

For further information:

 

 

Superdry Plc

 

Ruth Daniels

Company Secretary

+44 (0) 1242 586643

 

 


ISIN:GB00B60BD277
Category Code:DSH
TIDM:SDRY
LEI Code:213800GAQMT2WL7BW361
Sequence No.:178164
EQS News ID:1409373
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
31st May 20199:30 amRNSTotal Voting Rights
22nd May 20197:00 amRNSSuperdry - Interim Chief Financial Officer
14th May 201911:24 amRNSDirector/PDMR Shareholding
9th May 20197:00 amRNSPre-Close Trading Statement
30th Apr 201912:28 pmRNSTotal Voting Rights
17th Apr 201910:39 amRNSAppointment of Corporate Broker
16th Apr 20192:05 pmRNSDirector/PDMR Shareholding
11th Apr 20199:57 amRNSHolding(s) in Company
11th Apr 20199:57 amRNSHolding(s) in Company
8th Apr 201910:41 amRNSDirectorate Change
8th Apr 201910:35 amRNSDirector Declaration
5th Apr 20192:10 pmRNSHolding(s) in Company
2nd Apr 20194:45 pmRNSBroker Resignation
2nd Apr 20194:44 pmRNSBoard Changes
2nd Apr 20191:50 pmRNSResult of General Meeting
2nd Apr 201911:30 amRNSGeneral Meeting - Proxy Vote Update
29th Mar 20199:54 amRNSTotal Voting Rights
27th Mar 20199:00 amRNSHolding(s) in Company
25th Mar 201910:09 amRNSBlock listing Interim Review
14th Mar 201912:55 pmRNSDirector/PDMR Shareholding
14th Mar 20199:30 amRNSDistribution of Members Statement
11th Mar 20197:00 amRNSNotice of General Meeting
1st Mar 20196:14 pmRNSGeneral Meeting Request
28th Feb 201911:06 amRNSTotal Voting Rights
21st Feb 20194:18 pmRNSHolding(s) in Company
14th Feb 20193:41 pmRNSDirector/PDMR Shareholding
7th Feb 20197:00 amRNSQ3 Trading Statement
31st Jan 201910:43 amRNSTotal Voting Rights
29th Jan 201910:35 amRNSDirector/PDMR Shareholding
29th Jan 201910:34 amRNSDirector/PDMR Shareholding
15th Jan 20191:35 pmRNSDirector/PDMR Shareholding
9th Jan 20193:00 pmRNSHolding(s) in Company
8th Jan 201912:11 pmRNSBrigitte Danielmeyer
4th Jan 20191:55 pmRNSHolding(s) in Company
31st Dec 201811:35 amRNSTotal Voting Rights
27th Dec 20189:00 amRNSHolding(s) in Company
18th Dec 201812:02 pmRNSDirector/PDMR Shareholding
18th Dec 201810:24 amRNSDirector/PDMR Shareholding
17th Dec 20182:45 pmRNSDirector/PDMR Shareholding
17th Dec 20181:20 pmRNSDirector/PDMR Shareholding
14th Dec 20185:14 pmRNSHolding(s) in Company
14th Dec 20183:13 pmRNSHolding(s) in Company
14th Dec 201812:01 pmRNSDirector/PDMR Shareholding
13th Dec 20183:49 pmRNSHolding(s) in Company
13th Dec 20183:48 pmRNSHolding(s) in Company
12th Dec 20184:35 pmRNSPrice Monitoring Extension
12th Dec 20187:00 amRNSHalf-year Report
30th Nov 201811:27 amRNSTotal Voting Rights
28th Nov 201810:11 amRNSBlock Listing Application
15th Nov 20181:14 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.